How Long to Hold Clopidogrel (Plavix) Before a Procedure
For most elective procedures with high bleeding risk, discontinue clopidogrel 5 days before surgery, though 7-10 days is recommended for procedures with very high bleeding risk. 1, 2
Procedure-Specific Recommendations
High Bleeding Risk Procedures (Non-Cardiac Surgery, Major Procedures)
- Discontinue clopidogrel 7-10 days before the procedure if it can be done safely 1
- This allows adequate platelet recovery since clopidogrel inhibits platelets for their entire 7-10 day lifespan 2
- Continue aspirin if cardiovascular risk is high 1
CABG Surgery
- Discontinue clopidogrel at least 5 days before surgery (Class I, Level B recommendation) 1, 3, 4
- For low ischemic risk patients: stop 5 days prior
- For high ischemic risk AND high bleeding risk: stop 3-5 days prior
- For high ischemic risk AND low bleeding risk: surgery can proceed immediately 1
- Continue aspirin up to surgery 1, 3
Low Bleeding Risk Procedures
- Continue clopidogrel through the procedure for:
Arthrocentesis
Critical Timing Considerations for Stent Patients
This is where mortality risk becomes paramount:
Recent Stent Placement
- Bare Metal Stent (BMS): Defer elective surgery for ≥6 weeks after placement 1, 3
- Drug-Eluting Stent (DES): Defer elective surgery for ≥12 months after placement 1, 3
Urgent Surgery in Stent Patients
- If surgery required within 6 weeks of BMS or 12 months of DES: Continue BOTH aspirin AND clopidogrel perioperatively (Class I, Level B) 1, 3
- Stent thrombosis in the postoperative period carries up to 45% risk of MI or death 3
Evidence Quality and Nuances
The Canadian Cardiovascular Society guidelines [1-1] provide the most comprehensive framework, though they acknowledge limited direct evidence. The 2022 CHEST guidelines 4 support similar timing for CABG (≥5 days).
Important caveats:
The 5-day rule for CABG is well-established based on trial data showing 50-70% increased bleeding/transfusion risk with exposure <5 days 3, 4
The 7-10 day recommendation for other procedures is more conservative (Class IIb-IIa, Level C evidence), reflecting less robust data [1-1]
Recent research challenges these timelines: One small RCT 5 found no increased bleeding with continued clopidogrel in general surgery, and another study 6 found no difference in bleeding between 3-day vs 5-day cessation before CABG. However, these are single-center studies with small sample sizes and should not override guideline recommendations.
The FDA label 2 states: "When possible, interrupt therapy with Plavix for five days prior to such surgery" for procedures with major bleeding risk.
Practical Algorithm
Step 1: Determine if patient has recent stent
- Yes → Follow stent timing above (defer surgery or continue dual antiplatelet therapy)
- No → Proceed to Step 2
Step 2: Assess procedure bleeding risk
- High risk (major surgery, CABG, procedures in closed spaces): Stop 5-10 days prior
- Low risk (minor dental/skin/eye): Continue through procedure
Step 3: Assess cardiovascular risk
- High CV risk + high bleeding risk procedure: Stop clopidogrel 5-10 days prior but continue aspirin
- Low CV risk + high bleeding risk procedure: Stop both clopidogrel (5-10 days) and aspirin (7-10 days)
Step 4: Resume clopidogrel as soon as hemostasis is achieved postoperatively 2
Common Pitfalls
- Don't delay urgent/emergent surgery for clopidogrel washout - the bleeding risk is manageable with meticulous hemostasis and available platelets 7
- Don't stop clopidogrel in recent stent patients undergoing urgent surgery - the thrombosis risk far exceeds bleeding risk 1, 3
- Don't forget aspirin management - it should often be continued even when clopidogrel is stopped 1
- Don't use the 5-day rule universally - it's specific to CABG; other procedures may warrant 7-10 days 1